The current crisis of the COVID-19 pandemic will, most
likely, abate in due course as herd immunity builds up in all
affected countries [1]. Among all public health projects that
are stalled now, global polio eradication is a critical one and
it ought to be put back on rail. However, we foresee formidable
obstacles and propose remedial actions.
At a global level, on 24 March, 2020, the leadership of global
polio eradication recommended suspending all OPV campaigns until
at least second half of the year to prevent spread of SARS-CoV-2
[2]. Globally, vaccine derived polio virus (VDPV) type 2
outbreaks were not getting contained by OPV campaigns [3], and
they may expand and spread widely as lockdowns are lifted in the
affected countries. We may see resurgence of wild-virus polio in
Afghanistan and Pakistan.
In India, all activities under the Universal immunisation
programme (UIP) were stalled at the start of the lockdown, and
later resumed in different parts of the country amidst patchy
availability of public transport. There are consequences,
affecting all vaccine-preventable diseases, but here we focus on
the problems of polio as it is under eradication mode. The major
risk in India and in all countries still using bivalent OPV with
types 1 and 3, is the likelihood of emergence of VDPVs type 1
and type 3 [4], on account of long periods of no immunization
following its widespread use until January-February 2020,
including national pulse immunization in January, 2020. It is to
prevent the emergence of VDPVs that India’s UIP had been keeping
up high herd immunity in children through OPV under UIP plus
annual pulse campaigns twice annually, in spite of eradication
of wild polioviruses in 2014. As polio immunization is
suspended, India must anticipate the emergence and circulation
of VDPVs. We will know the full picture only after the lockdown
is lifted and surveillance for acute flaccid paralysis (AFP) and
for polioviruses is resumed.
We feel that the safest strategy to mitigate this impending risk
of VDPVs is to prepare for intensified immunization with IPV,
aiming to not reintroduce OPV in children in India after
achieving high IPV coverage. Full IPV immunization requires
priming and boosting. If a high proportion of children are
protected with full immunizing schedule of IPV adding booster
dose(s), the chances of VDPV emergence will be minimized and any
emerged VDPV transmission can be intercepted.
It is time for us to make these policy decisions after dialogue
with stake-holders, supported by science and evidence
accumulated in the country over the past 6 decades – and choose
the path which is in the best interests of our children.
Funding:
None; Competing
interests: None
stated.
REFERENCES
1. John TJ.
Will Coronavirus pandemic eventually evolve as Pan-endemic? Curr
Sci. 2020;118:855-6.
2. Global Polio Eradication
Initiative. Call to action to support COVID-19 response.
Available from:
http://polioeradication.org/news-post/call-to-action-to-support-covid-19-response.
Accessed April 25, 2020.
3. Centers for Disease
Control and Prevention. Update on Vaccine-Derived Poliovirus
Outbreaks — Worldwide, July 2019–February 2020; MMWR.
2020;69:489-95.
4. World Health
Organization. Polio outbreak in Papua New Guinea. Geneva: WHO;
2018 [cited 2019 Oct 7]. Available from:
https://www.who.int/westernpacific/emergencies/
papua-new-guinea-poliovirus-outbreak. Accessed May 8, 2020.